This inventor holds 3 USPTO granted patents. Top assignees: Jiangsu Simcere Pharmaceutical Co., Ltd., Nanjing Nuoyuan Medical Devices Co., Ltd, Simcere Pharmaceutical Co., Ltd.. Active years: 2026.
IDiyas Innovation Intelligence. (2026). Inventor Profile: Feng Wang. Retrieved from https://idiyas.com/inventor/feng-wang-ubc4w8yo
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Average Co-Inventor Count = 7.0
Company Filing History:
1 out of 3 Jiangsu Simcere Pharmaceutical Co., Ltd.
1 out of 2 Nanjing Nuoyuan Medical Devices Co., Ltd
1 out of 4 Simcere Pharmaceutical Co., Ltd.
Years Active: 2026
Loading Chart...
3 patents (USPTO):Explore Patents
Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
IDiyas Innovation Intelligence. (2026). Inventor Profile: Feng Wang. Retrieved from https://idiyas.com/inventor/feng-wang-ubc4w8yo
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents pending (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents pending (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]